{
    "eid": "2-s2.0-85106530856",
    "title": "Jorunnamycin a suppresses stem-like phenotypes and sensitizes cisplatin-induced apoptosis in cancer stem-like cell-enriched spheroids of human lung cancer cells",
    "cover-date": "2021-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)",
            "@code": "3001",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Cancer stem-like cells",
        "Cisplatin",
        "Jorunnamycin A",
        "Lung cancer",
        "Stemness transcription factors",
        "\u03b2-catenin"
    ],
    "authors": [
        "Somruethai Sumkhemthong",
        "Supakarn Chamni",
        "Gea U. Ecoy",
        "Pornchanok Taweecheep",
        "Khanit Suwanborirux",
        "Eakachai Prompetchara",
        "Pithi Chanvorachote",
        "Chatchai Chaotham"
    ],
    "citedby-count": 5,
    "ref-count": 84,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Cancer statistics, 2020",
        "Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer",
        "Understanding cancer stem cell heterogeneity and plasticity",
        "The role of cancer stem cells in recurrent and drug-resistant lung cancer",
        "Mechanisms of chemoresistance in cancer stem cells",
        "Lung cancer stem cells-origin, characteristics and therapy",
        "Targeting lung cancer stem cells: Research and clinical impacts",
        "Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer",
        "Cisplatin resistance induced by decreased apoptotic activity in non-small-cell lung cancer cell lines",
        "Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling",
        "Current perspectives in cancer immunotherapy",
        "Immunotherapy: From advanced NSCLC to early stages, an evolving concept",
        "Pulmonary adenocarcinoma in malignant pleural effusion enriches cancer stem cell properties during metastatic cascade",
        "Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells",
        "Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment",
        "Utilization of lung cancer cell lines for the study of lung cancer stem cells",
        "CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist",
        "Characterisation of a subpopulation of CD133(+) cancer stem cells from Chinese patients with oral squamous cell carcinoma",
        "The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance",
        "The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells",
        "Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG",
        "Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells",
        "Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling",
        "Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway",
        "Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of beta-catenin and Oct-4",
        "Gigantol suppresses cancer stem cell-like phenotypes in lung cancer cells",
        "Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer",
        "Jorunnamycins A-C, new stabilized renieramycin-type bistetrahydroisoquinolines isolated from the Thai nudibranch Jorunna funebris",
        "Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics",
        "Chemistry of renieramycins. 17. a new generation of renieramycins: Hydroquinone 5-O-monoester analogues of renieramycin M as potential cytotoxic agents against non-small-cell lung cancer cells",
        "Chemistry of Renieramycins. 15. Synthesis of 22-O-ester derivatives of jorunnamycin A and their cytotoxicity against non-small-cell lung cancer cells",
        "Chemistry of renieramycins. Part 19: Semi-syntheses of 22-O-amino ester and hydroquinone 5-O-amino ester derivatives of renieramycin M and their cytotoxicity against non-small-cell lung cancer cell lines",
        "Renieramycin M attenuates cancer stem cell-like phenotypes in H460 lung cancer cells",
        "Jorunnamycin A from Xestospongia sp. suppresses epithelial to mesenchymal transition and sensitizes anoikis in human lung cancer cells",
        "Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells",
        "Cell-of-origin of cancer versus cancer stem cells: Assays and interpretations",
        "Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells",
        "Lung stem and progenitor cells in tissue homeostasis and disease",
        "CD133: Beyond a cancer stem cell biomarker",
        "Clinicopathological significance of CD133 in lung cancer: A meta-analysis",
        "Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis",
        "Genetic polymorphisms and platinum-based chemotherapy treatment outcomes in patients with non-small cell lung cancer: A genetic epidemiology study based meta-analysis",
        "Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity",
        "Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B",
        "3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained",
        "Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death",
        "The emerging treatment landscape of targeted therapy in non-small-cell lung cancer",
        "In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer",
        "NOTCH1 signaling regulates self-renewal and platinum chemoresistance of cancer stem-like cells in human non-small cell lung cancer",
        "Stemness in cancer: Stem cells, cancer stem cells, and their microenvironment",
        "Targeting cancer stem cell pathways for cancer therapy",
        "Cancer stem cell self-renewal as a therapeutic target in human oral cancer",
        "Targeting self-renewal pathways in cancer stem cells: Clinical implications for cancer therapy",
        "Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme",
        "Spheroid-formation (Colonosphere) assay for in vitro assessment and expansion of stem cells in colon cancer",
        "Sphere-formation assay: Three-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells",
        "Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells",
        "Pluripotency genes and their functions in the normal and aberrant breast and brain",
        "The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung",
        "Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation",
        "SOX2, a stemness gene, induces progression of NSCLC A549 cells toward anchorage-independent growth and chemoresistance to vinblastine",
        "Antineoplastic agents. 485. Isolation and structure of cribrostatin 6, a dark blue cancer cell growth inhibitor from the marine sponge Cribrochalina sp",
        "Targeting the PI3K/AKT/mTOR pathway: Potential for lung cancer treatment",
        "Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells",
        "PTEN tumor-suppressor: The dam of stemness in cancer",
        "Cells of origin in cancer",
        "The epithelial-to-mesenchymal transition in cancer",
        "VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation",
        "EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer",
        "Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: A multicenter phase II trial (GFPC 07-01)",
        "Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects",
        "Cisplatin-induced renal toxicity in elderly people",
        "Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC",
        "Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin-resistant non-small cell lung cancer",
        "p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis",
        "The p53-Bcl-2 connection",
        "Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer",
        "Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins",
        "FAK and Nanog cross talk with p53 in cancer stem cells",
        "5-O-acetyl-renieramycin T from blue sponge Xestospongia sp. induces lung cancer stem cell apoptosis",
        "Chemistry of renieramycins. Part 3.(1) isolation and structure of stabilized renieramycin type derivatives possessing antitumor activity from Thai sponge Xestospongia species, pretreated with potassium cyanide",
        "In vitro and in vivo limiting dilution assay for colorectal cancer",
        "Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-beta pathway"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cebu",
            "@id": "60071487",
            "affilname": "University of San Carlos",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071487",
            "affiliation-country": "Philippines"
        }
    ],
    "funding": [
        "C2F",
        "Ratchadaphiseksomphot Endowment Fund",
        "Chulalongkorn University",
        "National Research Council of Thailand"
    ]
}